Pentosan Polysulfate Sodium

木聚硫钠

Report date: 2026/05/02 20:00:18
NME

Base Information

Drug NamePentosan Polysulfate Sodium
Drug Alias Namenatrii pentosani polysulfas戌聚糖聚硫酸钠pentosane polysulfate sodiquepentosano polisulfato de sodioNaPPS +[11] 
ClassificationSmall molecules > Carbohydrate
Mechanisms of ActionCell membrane permeability inhibitorsReverse transcriptase inhibitors
TargetsReverse transcriptase
Therapy Area/IndicationsDiarrheaPainCommon Variable Immunodeficiency +[7] 
Global Approved IndicationsPainCystitis, Interstitial
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1996/09/26
Country/TerritoryCanadaUnited StatesAustralia +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesIvax CorpTeva
China Registration ClassN/A

Develop Information

Active CompaniesJanssen Pharmaceuticals IncBene-Arzneimittel GmbhIvax Asia Ltd +[4] 
Inactive CompaniesInstitut National De La Santé Et De La Recherche Médicale, France U979Mcneil Consumer & Specialty Pharmaceuticals, A Division Of Mcneil-Ppc IncNational Cancer Institute
Active IndicationsPainCystitis, InterstitialOsteoarthritis, Knee
Inactive IndicationsDiarrheaCommon Variable ImmunodeficiencyProstatitis +[4] 

Other Information

ATC CodeC05BA04G04BX15
Related LinksWikipediaDrugBankKEGG